Back to company

GB PHARMA ApS: Financial statements 2019

CVR: 36054220

GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 46,665 and a net result of DKK 24,575 compared with DKK 41,349 the year before. That is an increase of 8.6% compared with the year before. The profit margin was 52.7%. Equity amounted to DKK -1,920,789.

Revenue
46,665 kr.
Gross Profit
18,992 kr.
Profit/Loss
24,575 kr.
Equity
-1,920,789 kr.
Total Assets
43,758 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
201947 t.19 t.25 t.-1.9 mio.0
201843 t.23 t.41 t.-1.9 mio.0
2017-9 t.50 t.-2 mio.0
2016--426 t.-664 t.-2.7 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

GB PHARMA ApS: The 2018 annual report is outMay 24, 2019

GB PHARMA ApS has published its annual report for 2018. Revenue came to DKK 42,975, and the net result was DKK 41,349.

About GB PHARMA ApS

GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The company is owned by Gunnar Kjems. The company has 0 employees. In 2025, the company reported revenue of DKK 0 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity amounted to DKK -1,902,842.